Compensatory Substitutions in the HIV-1 Capsid Reduce the Fitness Cost Associated with Resistance to a Capsid-Targeting Small-Molecule Inhibitor

The HIV-1 capsid plays multiple roles in infection and is an emerging therapeutic target. The small-molecule HIV-1 inhibitor PF-3450074 (PF74) blocks HIV-1 at an early postentry stage by binding the viral capsid and interfering with its function. Selection for resistance resulted in accumulation of...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Virol
Asıl Yazarlar: Shi, Jiong, Zhou, Jing, Halambage, Upul D., Shah, Vaibhav B., Burse, Mallori J., Wu, Hua, Blair, Wade S., Butler, Scott L., Aiken, Christopher
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society for Microbiology 2014
Konular:
Vaccines and Antiviral Agents
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4301104/
https://ncbi.nlm.nih.gov/pubmed/25320302
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.01411-14
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller